Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropsychiatric lupus

S G West1

  • 1Department of Medicine, Fitzsimons Army Medical Center, Aurora, Colorado.

Rheumatic Diseases Clinics of North America
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Neuropsychiatric disease affects many systemic lupus erythematosus patients, presenting diverse symptoms. Understanding lupus cerebritis pathogenesis aids tailored diagnosis and therapy for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress responses to repeated exposure to a combined physical and social evaluative laboratory stressor in young healthy males.

Psychoneuroendocrinology·2015
Same author

Effects of a DASH-like diet containing lean beef on vascular health.

Journal of human hypertension·2014
Same author

Acute effects of pistachio consumption on glucose and insulin, satiety hormones and endothelial function in the metabolic syndrome.

European journal of clinical nutrition·2014
Same author

Personalism and cognitive labels as determinants of attitude attribution.

Memory & cognition·2013
Same author

Nutrient displacement associated with walnut supplementation in men.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2013
Same author

Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE).

Lupus·2012
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Neuropsychiatric disease affects up to two-thirds of patients with systemic lupus erythematosus.
  • Current classification of neuropsychiatric manifestations is limited, often categorized into diffuse, focal, and seizure presentations.
  • Understanding the pathogenesis of lupus cerebritis has advanced significantly.

Purpose of the Study:

  • To review the current understanding of neuropsychiatric disease in systemic lupus erythematosus.
  • To discuss the classification and diagnostic approaches to lupus cerebritis.
  • To highlight the impact of understanding pathogenesis on therapeutic strategies.

Main Methods:

  • Literature review of recent advancements in lupus cerebritis research.

Related Experiment Videos

  • Analysis of diagnostic and therapeutic approaches based on underlying etiopathogenesis.
  • Discussion of future directions in managing neuropsychiatric lupus erythematosus.
  • Main Results:

    • Neuropsychiatric manifestations in systemic lupus erythematosus are common and diverse.
    • Pathogenesis of lupus cerebritis is increasingly understood, enabling targeted interventions.
    • Tailored diagnostic and therapeutic strategies show promise for improved patient management.

    Conclusions:

    • Improved understanding of lupus cerebritis pathogenesis allows for more personalized patient care.
    • Future therapeutic advancements are expected to enhance the prognosis for patients with neuropsychiatric lupus erythematosus.
    • A refined classification and approach to diagnosis and therapy are crucial for managing this complex condition.